JP2024531115A5 - - Google Patents
Info
- Publication number
- JP2024531115A5 JP2024531115A5 JP2024506883A JP2024506883A JP2024531115A5 JP 2024531115 A5 JP2024531115 A5 JP 2024531115A5 JP 2024506883 A JP2024506883 A JP 2024506883A JP 2024506883 A JP2024506883 A JP 2024506883A JP 2024531115 A5 JP2024531115 A5 JP 2024531115A5
- Authority
- JP
- Japan
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163234344P | 2021-08-18 | 2021-08-18 | |
| US63/234,344 | 2021-08-18 | ||
| PCT/US2022/040540 WO2023023112A1 (en) | 2021-08-18 | 2022-08-17 | Process for preparing histone demethylase inhibitors |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2024531115A JP2024531115A (ja) | 2024-08-29 |
| JPWO2023023112A5 JPWO2023023112A5 (https=) | 2025-08-21 |
| JP2024531115A5 true JP2024531115A5 (https=) | 2025-08-21 |
Family
ID=85239709
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024506883A Pending JP2024531115A (ja) | 2021-08-18 | 2022-08-17 | ヒストン脱メチル化阻害剤を調製するためのプロセス |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20250129056A1 (https=) |
| EP (1) | EP4387961A4 (https=) |
| JP (1) | JP2024531115A (https=) |
| AU (1) | AU2022331536A1 (https=) |
| CA (1) | CA3227684A1 (https=) |
| WO (1) | WO2023023112A1 (https=) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20200039938A1 (en) | 2017-03-30 | 2020-02-06 | Albert-Ludwigs-University Freiburg | Kdm4 inhibitors |
| WO2022217100A1 (en) * | 2021-04-09 | 2022-10-13 | Tachyon Therapeutics, Inc. | Treatment of cancer with kdm4 inhibitors |
| CN120225189A (zh) * | 2022-09-21 | 2025-06-27 | 细胞基因公司 | 组蛋白去甲基化酶抑制剂3-({[(4r)-7-{甲基[4-(丙烷-2-基)苯基]氨基}-3，4-二氢-2h-1-苯并吡喃-4-基]甲基}氨基)吡啶-4-甲酸l-赖氨酸盐的结晶形式 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2013143597A1 (en) * | 2012-03-29 | 2013-10-03 | Glaxo Group Limited | Demethylase enzymes inhibitors |
| AR100997A1 (es) * | 2014-06-25 | 2016-11-16 | Quanticel Pharmaceuticals Inc | Derivados de piridina como inhibidores de histona demetilasa |
| US20200039938A1 (en) * | 2017-03-30 | 2020-02-06 | Albert-Ludwigs-University Freiburg | Kdm4 inhibitors |
-
2022
- 2022-08-17 CA CA3227684A patent/CA3227684A1/en active Pending
- 2022-08-17 AU AU2022331536A patent/AU2022331536A1/en active Pending
- 2022-08-17 JP JP2024506883A patent/JP2024531115A/ja active Pending
- 2022-08-17 EP EP22859079.0A patent/EP4387961A4/en active Pending
- 2022-08-17 US US18/682,370 patent/US20250129056A1/en active Pending
- 2022-08-17 WO PCT/US2022/040540 patent/WO2023023112A1/en not_active Ceased